Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
World News GlobalNewswire Jul 20, 2026
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
World News GlobalNewswire Jul 20, 2026